SCHEMBL20704872

SCHEMBL20704872

COc1cc2[nH]cc(C(=O)O)c(=O)c2c(OC)c1OC

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MTNR1A P48039 1/20 0.50
▸ MTNR1B P49286 1/20 0.50
▸ KDM4E B2RXH2 4/20 0.47
▸ ALDH1A1 P00352 4/20 0.47
▸ HPGD P15428 3/20 0.47
▸ TUBB1 Q9H4B7 1/20 0.45
▸ HSD17B10 Q99714 3/20 0.43
▸ CYP1A2 P05177 2/20 0.43
▸ PKM P14618 1/20 0.43
▸ HTT P42858 1/20 0.42
▸ GAA P10253 1/20 0.42
▸ ALOX15 P16050 1/20 0.42
▸ MAPK1 P28482 1/20 0.41
▸ POLB P06746 2/20 0.41
▸ GRIN2D O15399 1/20 0.41
▸ GRIN3B O60391 1/20 0.41
▸ GRIN1 Q05586 1/20 0.41
▸ GRIN2A Q12879 1/20 0.41
▸ GRIN2B Q13224 1/20 0.41
▸ GRIN2C Q14957 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14845164 0.84 PRKAB2 (0.50) KDM4EALDH1A1HPGDHSD17B10CYP1A2
SCHEMBL20704553 0.84 MTNR1A (0.46) MTNR1AMTNR1BKDM4EALDH1A1HPGD
SCHEMBL20704865 0.83 GABRA1 (0.51) MTNR1AMTNR1BALDH1A1HPGDTUBB1
SCHEMBL20704836 0.82 MTNR1A (0.47) MTNR1AMTNR1BKDM4EALDH1A1HPGD
SCHEMBL30309869 0.81 CFTR (0.54) MTNR1AMTNR1BKDM4EALDH1A1HPGD
SCHEMBL20704840 0.81 CFTR (0.54) MTNR1AMTNR1BKDM4EALDH1A1HPGD
SCHEMBL20704965 0.81 ALDH1A1 (0.48) KDM4EALDH1A1HPGDTUBB1HSD17B10
SCHEMBL20704809 0.78 POLB (0.51) MTNR1AMTNR1BKDM4EALDH1A1HPGD
SCHEMBL9424983 0.78 KDM4E (0.64) MTNR1AMTNR1BKDM4EALDH1A1HPGD
SCHEMBL1562296 0.77 TUBB1 (0.61) MTNR1AMTNR1BTUBB1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230113225-A1 INHIBITORS OF MICROBIALLY INDUCED AMYLOID AXIAL THERAPEUTICS, INC. (US) 2023-04-13 — — US disclosed
US-20230103887-A1 INHIBITORS OF MICROBIALLY INDUCED AMYLOID AXIAL THERAPEUTICS, INC. (US) 2023-04-06 — — US disclosed
US-11505528-B2 Inhibitors of microbially induced amyloid AXIAL THERAPEUTICS, INC. (US) 2022-11-22 — — US disclosed
US-11505528-B2 Inhibitors of microbially induced amyloid AXIAL THERAPEUTICS, INC. (US) 2022-11-22 — — US disclosed
US-20200290970-A1 INHIBITORS OF MICROBIALLY INDUCED AMYLOID AXIAL BIOTHERAPEUTICS, INC. (US) 2020-09-17 — — US disclosed
US-20200290970-A1 INHIBITORS OF MICROBIALLY INDUCED AMYLOID AXIAL BIOTHERAPEUTICS, INC. (US) 2020-09-17 — — US disclosed
EP-3664822-A1 INHIBITORS OF MICROBIALLY INDUCED AMYLOID Axial Biotherapeutics, Inc. (US) 2020-06-17 — — EP disclosed
WO-2019028456-A1 INHIBITORS OF MICROBIALLY INDUCED AMYLOID AXIAL BIOTHERAPEUTICS, INC. (US) 2019-02-07 — — WO disclosed
WO-2019028456-A1 INHIBITORS OF MICROBIALLY INDUCED AMYLOID AXIAL BIOTHERAPEUTICS, INC. (US) 2019-02-07 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230103887-A1 INHIBITORS OF MICROBIALLY INDUCED AMYLOID SNCA, PARK7, PRNP MTNR1A 871/4885MTNR1B 1143/4885KDM4E 4800/4885
US-11505528-B2 Inhibitors of microbially induced amyloid SNCA, PARK7, PRNP MTNR1A 871/4885MTNR1B 1143/4885KDM4E 4800/4885
US-20230113225-A1 INHIBITORS OF MICROBIALLY INDUCED AMYLOID SNCA, PARK7, PRNP MTNR1A 858/4885MTNR1B 995/4885KDM4E 4820/4885
US-20200290970-A1 INHIBITORS OF MICROBIALLY INDUCED AMYLOID SNCA, PARK7, PRNP MTNR1A 871/4885MTNR1B 1143/4885KDM4E 4800/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback